Obs and gynae Flashcards

1
Q

What is menopause and what is average age?

A

the permeant cessation of the menstruation due to the loss of ovarian follicular function (amenorrhea for 12 months except when on pill or pathological) this is when there is no obvious pathological or physiological cause present
Average age in the UK is 51

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is perimenopause?

A

no consistent definition, a period of changing ovarian function which precedes menopause by 2-8 years. Includes the period beginning with the first clinical, biological, and endocrinological features of the approaching menopause, such as vasomotor symptoms and menstrual irregularity, and ends 12mths after the last menstrual period.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is premature ovarian failure? What are the causes, and features?

A

Premature ovarian failure is defined as the onset of menopausal symptoms and elevated gonadotrophin levels before the age of 40 years.
Unlike the menopause, premature ovarian insufficiency can be areversiblecondition so is not termed an early menopause.

It occurs in around 1 in 100 women.

Causes
Primary:
	• Chromosomal abnormalities 
	• FSH receptor gene polymorphisms and inhibin B mutation 
	• Enzyme deficiency 
	• Autoimmune disease 
Secondary
	• Chemotherapy and radiation
	• Bilateral oophorectomy or surgical menopause 
	• Hysterectomy without oophorectomy 
	• Infection 
Clinical presentation 
	• Secondary amenorrhoea or oligomenorrhoea (which may not be necessarily accompanied by hot flushes- infertility
	• Co existing disease may be detected particularly 
		○ Hypothyroidism 
		○ Addisons's
		○ DM 
		○ Any chromosomal abnormalities 
Investigations
raised FSH, LH levels
If diagnosis in doubt consider anti MH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is pre-menopause?

A

a term often used to refer either to the 1–2yrs immediately before the menopause or to the whole of the reproductive period before the menopause. Currently, this term is recommended to be used in the latter sense.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is post menopause?

A

should be defined from the final menstrual period regardless of whether the menopause was induced or spontaneous.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is menopausal transition?

A

is the period of time before the final menstrual period, when variability in the menstrual cycle usually is increased.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is climacteric?

A

is the phase encompassing the transition from the reproductive state to the non-reproductive state. The menopause itself thus is a specific event that occurs during the climacteric, just as the menarche is a specific event that occurs during puberty.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the vasomotor symptoms of menopause?

A

• Hot flushes
• Night sweats
• HIGHEST AFTER THE FMP
• <5 years often but some continue to 70s
• A sudden feeling of heat in the upper body (face, neck, and chest) which spreads upwards and downwards.
• In some cases, this will become generalized, lasting for several minutes, and can be associated with excessive sweating, palpitations, or anxiety.
This can be very distressing for the woman, especially when it happens repeatedly during the day and at night.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the changes in sexual behaviour/activity in menopause?

A

Loss of sexual desire
• Loss of sexual arousal
• Problems with orgasm
• Sexual pain such as painful sex or dyspareunia
• % rises from 42-88% in early-> late menopause
• Vaginal dryness- reduced oestrogen-> dyspareunia
• Less sexual desire-> low androgen?
• Non hormonal factors: conflict between partners, life stress, depression
Male sexual problems should not be overlooked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the psychological problems in menopause?

A
• Depressed  mood 
• Anxiety 
• Irritability and mood swing s
• Lethargy and lack of energy 
Likely due to past problems or current life stresse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the LT consequence of osteoporosis?

A

• Shift to bone reabsorption
• Osteoporosis is a significant RF for fracture- fractures are a clinical consequence of osteoporosis
• Lower end of the radius (wrist or colle’s fracture)
• Proximal femur (hip)
Vertebrae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the LT consequences of cardiovascular disease?

A

• MI and stroke are the primary clinical endpoints
• CVD is the most common cause of death in women >60
• Oophorectomized women are 2-3 fold higher risk of CHD than age matched pre menopausal women
Increase LDL reduced HDL without oestrogren

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the LT urogenital atrophy?

A

lower Urinary + genital tracts have a common embryological origin
• Oestrogen receptors and progesterone receptors are on vagina, urethra, bladder and pelvic floor muscles
• Oestrogen deficiency after menopause causes atrophic changes within the urogenital tract-> urinary symptoms: frequency, urgency, nocturia, incontinence and recurrent infection
May also co-exist with those of vaginal atrophy, including dyspareunia, itching, burning and dryness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the prognosis for premature menopause women?

A

• Women with untreated premature menopause (no oestrogen replacement) are at increased risk of osteoporosis and cardiovascular disease, but at lower risk of breast malignancy.
• Premature menopause can lead to reduced peak bone mass (if <25yrs old) or early bone loss thereafter.
Mean life expectancy in women with menopause before the age of 40yrs is 2.0yrs shorter than that in women with menopause after the age of 55yrs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the treatment of premature ovarian failure?

A

Multidisciplinary team to manage both the psychological impact of the condition alongside the physical symptoms.HRTis the main treatment, alongside monitoring for cardiovascular disease and osteoporosis.
There are a few management issues:
• Fertility and contraception:
○ Reduced fertility
○ May require assisted conception
○ Need for contraception if no fertility goals
• Women need oestrogen replacement until average of natural menopause- 51
○ HRT
COCP without gaps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are some DDx of menopause including hot flushes, irregular bleeding (perimenopause, and after menopause), vaginal atrophy, incontinence, mood changes, cognitive disturbances, libido, muscle and joint pains, skin changes, weight gain?

A

• Causes of amenorrhoea
• Irregular bleeding:
• During the perimenopause, possible causes include endometrial polyps; uterine fibroids; adenomyosis; endometrial hyperplasia or cancer; and vulval, vaginal, or cervical lesions.
• After menopause, possible causes include endometrial atrophy; vaginal atrophy; endometrial polyps; endometrial hyperplasia or cancer; and vulval, vaginal, or cervical lesions.
• Hot flushes:
If ovarian failure is uncertain, exclude other causes such as:
• Endocrine causes, for example, hyperthyroidism and phaeochromocytoma.
• Tumours, for example, carcinoid tumour, pancreatic tumour, mastocytoma, and paraneoplastic syndrome.
• Excess alcohol consumption.
• Dumping syndrome.
• Panic disorders.
• Tuberculosis.
• Drugs, for example, nitrates, selective serotonin reuptake inhibitors (SSRIs), diltiazem, levodopa, gonadotrophin-releasing hormone agonists, and anti-oestrogens
• Vaginal atrophy: trauma or infection
Symptoms that are associated with the menopause but are often due to other causes include:
• Urinary incontinence—this is more likely to be due to mechanical factors, such as obesity, gynaecological surgery, or multiparity, than the menopause.
• Mood changes(including anxiety, irritability, and depression)—these symptoms may not be due to the menopause alone. General population studies suggest that most women do not experience major changes in mood during the menopause transition; however, anxiety and depression should be excluded
• Cognitive disturbances(such as forgetfulness or difficulty concentrating)—cross-sectional studies suggest that these symptoms are unlikely to be related to the menopause.
• Loss of libido—this symptom can be attributed to androgen deficiency; however, non-hormonal factors, such as insomnia, inadequate sexual stimulation, life stresses, and depression, are also important possible contributors.
• Muscle and joint pains—pain and swelling resulting in restriction of mobility most often affects the small joints of the hands and feet as well as the knees, elbows, and the cervical spine. These symptoms have been linked to a decrease in oestrogen levels, but musculoskeletal causes (such as osteoarthritis and rheumatoid arthritis) are possible.
• Skin changes—it is difficult to separate skin changes due to ageing, smoking, and sun exposure, from skin changes due to declining hormonal secretion and menopause. Soon after the menopause, skin collagen content and skin thickness decrease, resulting in decreased skin elasticity.
•Weight gain—this is unlikely to be solely due to the perimenopause or the menopause. Body weight in women tends to increase with age, especially beginning at or near the menopause (the average weight gain ranges from 2.25–4.19 kg). Body fat redistribution to the abdomen also occurs with age (independently of weight gain).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the epidemiology of menopause, how long do symptoms last, and what is duration and severity?

A

• Menopausal symptoms are very common and affect roughly 75% of postmenopausal women
Symptoms typically last for 7 years but may resolve quicker and in some cases take much longer. The duration and severity are also variable and may develop before the start of the menopause and in some cases may start years after the onset of menopause.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the aetiology of menopause?

A
  • There is a reduction in oestrogen- this is due to a reduced sensitivity of the ovary to circulating gonadotrophins as a result of reduction in sensitivity of ovary to circulating gonadotrophins (FSH and LH) and marked decrease in sites due to reduction in follicle number
  • This results in anovulatory cycles
  • Levels of FSH and LH increase during menopause due to low oestrogen
  • The decrease in developing follicles- reduces inhibin- therefore increase increase in FSH

Women who progress towards menopause (perimenopausal) often have variety of symptoms- hot flushes, urinary incontinence and increase UTI as well as irregular bleeding (some from ovulatory cycles and others when endometrium proliferated under oestrogen but without progesterone from CL after ovulation as progesterone is needed to keep endometrium you get oestrogren breakthrough bleeding)
As levels of oestrogen decrease both of these bleedings decrease

19
Q

What are the pathophysiological observations seen in menopause?

A

• Reduce follicle count- none or few at menopause
• Reduce granulosa cell number
• Reduce granulosa function (those which are present have low function less estrogen, less good at responding to LH and FSH) and inhibin B (less good at inhibin A in luteal phase)- both are important as feedback and reduce FSH- very little break in FSH tend to loose more and more eggs
Increasing chromosomal abnormalities of oocytes

20
Q

Why does follicular depletion occur in menopause?

A

• Increased follicular death (apoptosis)
• Ovarian environment e.g smoking reduces age at menopause by mean of 2 years and shorter transition
• Accelerated follicular loss
• Anti Mullerian hormone declines, FSH increases, increase follicular recruitment and loss
Early on and increases towards menopause

21
Q

Why does the granulosa number and function decrease?

A

Decline in the granulosa number and function
• 30% decrease in granulosa cells in older woman c/w younger
• Decrease in inhibin B production from granulosa cells in follicular phase (allows higher FSH)
• Anovulatory cycles leads to less inhibin A as no luteal phase (allows higher FSH)
• Decrease FSH receptors number and sensitivity impairs recruitment dominant follicle
Impaired secretion growth factors and other signaling pathways, survival factors, estrogen and progesterone

22
Q

What are the short term or immediate effects of menopause?

A

Night sweats, hot flushes, mood symptoms- vasomotor - once the brain notices its in menopause may not need treatment

23
Q

What are the medium term effects of menopause?

A
Loss of libido
Superficial dyspareunia
Post coital bleeding- vaginal atrophy
Itchy 
Infection- thrush
Can get depression
UTIs 
Incontinence/prolapse (muscle relaxation) 
Skin changes - hyperpigmentation
24
Q

What are the prolonged effects of menopause

A

Amenorrhoea NO PERIODS
Lack of bone mineral density- osteoporosis + fractures - often present with aches and pains - calcium and vitamin D + bisphosphate + HRT (cancer risks)

25
Q

How do you investigate menopausal women?

A
→ History 
	• Symptoms, periods, contraception 
		○ Hot flushes and night sweats?
		○ Vaginal dryness
		○ Other symptoms 
		○ Date of LMP? Could she be pregnant?
		○ Frequency, heaviness, duration of periods?
		○ Contraception
	• Gynae history 
		○ Hysterectomy 
		○ Oophorectomy
	• PMH and PSH
		○ RF for osteoporosis 
		○ Confirmed DVT or PE 
		○ RF for CVD (Smoking, hypertension, DM)
		○ Breast cancer, benign breast disease, and date of last meammogram (if applicable)
		○ Migraines?
		○ Current medication?
		○ Alternative or complementary therapies?
	• Fx of close family members 
		○ Breast, ovarian or bowel cancer 
		○ Confirmed DVT or PE 
		○ CVD
		○ Osteoporosis
→ Examination
→ Investigations 
	• Hormone tests:
		○ FSH is only helpful if the diagnosis is in doubt  (E.g <40) and levels >30IU/L (as note that the levels tend to flucuate)
		○ LH, ostradiol and progesterone are no value in diagnosis of ovarian failure 
		○ TFT- as can mimic menopause 
BMD If significant RF for osteoporosis
26
Q

What are some lifestyle changes for menopause (hot flushes, sleep, mood, cognition)

A

Hot flushes
• regular exercise, weight loss and reduce stress
Sleep disturbance
• avoiding late evening exercise and maintaining good sleep hygiene
Mood
• sleep, regular exercise and relaxation
Cognitive symptoms
•regular exercise and good sleep hygiene

27
Q

What are the three areas to address with HRT?

A
  • whether there is a uterus or not
    • whether the patient is perimenopausal or menopausal
      • whether a systemic or local effect is required.
28
Q

What are the forms to be given for HRT?

A

• Uterus- oral or transdermal combined HRT
• No uterus- ostrogen orally or in transdermal
• Oestrogen+ Progestogen +androgen preparation –Tibolone –continuous
2 forms:
1. Cyclical HRT- (for perimenopausal women & with in 1year of cessation of period)
2. Continuous

Include oestrogens, progestogens, and other hormones like tibolone (metabolites include oestrogenic, progestogenic, and androgenic actions), testosterone (for libido)
Forms available:
	• Oral
		○ Tablets - daily
	•  Implants
		○ Twice yearly- on abdomen SC
	•  Transdermal
		○ Patch- once/twice weekly
		○ Gel- daily
Topical
29
Q

What are the indications of HRT?

A
  • Vaginal atrophy (topical preparations)
    • Vasomotor symptoms
    • Natural or surgical early menopause (<45 years)
    • Postmenopausal osteoporosis (other drugs are preferred)
30
Q

What are the side effects of HRT?

A

Main ones:
• Nausea & vomiting
• Cramping
• Bloating
• Weight changes
• breast tenderness & tenderness
• Pre menstrual like symptoms
• Sodium and fluid retention
→ Oestrogen-related: fluid retention, bloating, breast tenderness or enlargement, nausea, headaches, leg cramps, and dyspepsia.*
→ Progestagen-related: fluid retention, breast tenderness, headaches or migraine, mood swings, depression, acne, lower abdominal pain, and backache.*
→ Combined HRT: irregular, breakthrough bleeding (may need investigation).
→ All types of HRT: weight gain (but not proved in randomized trials). * Changing dose, type, and route of administration (tablet to patch) may help.

31
Q

What are the benefits of HRT?

A

Benefits:
• Reduction in vasomotor symptoms
• Reduction in urogenital symptoms and improved sexuality
• Reduced risk of osteoporosis
• Reduced risk of colorectal cancer

32
Q

What is the increased risk of breast cancer with HRT?

A

○ increased with progesterone, increased risk relates to duration, risk begins to decline when HRT stopped and by 5 years it reaches same level as those who have never taken- related risk of 1.26 at 5 year of developing
Note that dying from breast cancer is not raised

33
Q

What is the increased risk of endometrial cancer with unopposed oestrogen with HRT?

A

○ Oestrogen itself should not be given as HRT to women with womb
Reduced by addition of progesterone but not completely eliminated- BNF states that additional risk is eliminated with progesterone being given continuously

34
Q

What is the risk of VTE with HRT?

A

○ Increased with progesterone addition
○ Transdermal HRT does not appear to increase VTE
High risk for VTE should–> haematology before starting any treatment

35
Q

What is the risk of stroke, ischaemic heart disease, gallbladder disease risk with HRT?

A

• Increase risk of stroke
○ Slightly increased with oral oestrogen HRT
• Increase risk of ischaemic heart disease if >10 years
○ combined HRT may be associated with a slight increase in risk
• Risk of gallbladder disease

36
Q

What are the uncertainties with HRT?

A

• Cardiovascular disease- the role of HRT in primary and secondary prevention is uncertain and should not be used primarily for this indication
• Dementia and cognition- oestrogen may delay or decrease risk of AD but does not seem to imrpove establisehd
• Ovarian cancer: there is a increase risk in V. LT with ostrogen alone but not with conitnuous
QOL

37
Q

What are the contraindications for HRT

A
  • Current or past breast cancer
    • Any oestrogen-sensitive cancer- current endometrial ca or breast ca
    • Undiagnosed vaginal bleeding or undiagnosed breast lump
    • Pregnancy
    • Acute liver disease
    • Acute MI or stroke
    • Acute phase of DVT or PE
      • Untreated endometrial hyperplasia
38
Q

What are some management options for vasomotor symptom in menopause?

A

• SSRI’s: fluoxetine, citalopram, paroxetine
• Or SNRI venlafaxine
• Clonidine (α-agonist): once mainstay treatment, but now shown as
having limited effect.

39
Q

What are some management options for vaginal dryness and urogenital symptoms in menopause?

A

Vaginal dryness
vaginal lubricant or moisturiser
Urogenital symptoms
• if suffering from urogenital atrophy vaginal oestrogen can be prescribed. This is appropriate if they are taking HRT or not- in ring or tablets are most effective for treatment of vaginal atrophy or dyspareunia - assure for minimal systemic absorption and no need for progestagen
vaginal dryness can be treated with moisturisers and lubricants. These can be offered alongside vaginal oestrogens if required.

40
Q

What are some management of psychological symptoms/prevention/treatment of osteoporosis

A

Psychological symptoms
self-help groups, cognitive behaviour therapy or antidepressants
Prevention and treatment of osteoporosis:
• Calcium and vitamin D.
• Bisphosphonates (inhibits osteoclasts)
Selective oestrogen reuptake modulators (SERMs).

41
Q

When should women stop HRT?

A

For vasomotor symptoms, 2-5 years of HRT may be required with regular attempts made to discontinue treatment.
Vaginal oestrogen may be required long term.
When stopping HRT it is important to tell women that gradually reducing HRT is effective at limiting recurrence only in the short term. In the long term, there is no difference in symptom control.

42
Q

What is the usual dose of folic acid in pregnancy, and when would high dose be taken?

A

• 400mg folic acid before conception–> until 12 weeks (neural tube defects)- certain women need higher doses (anti epileptic)

- DNA production, growth and BC- uterus, placenta and fetus 
- Deficiency linked to spina bifida 
- Should start 3 months before 

Higher risk: women at higher risk of conceiving a child with a NTD should take 5mg of folic acid frombefore conceptionuntil the 12th week of pregnancy
women are considered higher risk if any of the following apply:
→ either partner has a NTD, they have had a previous pregnancy affected by a NTD, or they have a family history of a NTD
→ the woman is takingantiepileptic drugsor has coeliac disease,diabetes, or thalassaemia trait.
→ the woman isobese(defined as a body mass index [BMI] of 30 kg/m2 or more).

43
Q

What are some Category 4 for CI of COCP

A

more than 35 years old and smoking more than 15 cigarettes/day
migraine with aura
history of thromboembolic disease or thrombogenic mutation
history of stroke or ischaemic heart disease
breast feeding < 6 weeks post-partum
uncontrolled hypertension
current breast cancer
major surgery with prolonged immobilisation

44
Q

What are some antimuscarinics used to treat urge incontinence?

A

Oxybutynin, tolterodine, solifenacin